Dechert Re:Torts

• PFAS in the Spotlight: EPA and FDA Zero in on Seafood and Water
• Online Retailer Avoids Liability in Suicide Cases (For Now)
• AI Expert Challenged for Relying on AI “Hallucinations”
• Ohio Supreme Court Rules Public Nuisance Claims Against Retail Pharmacies Barred by State Law
• U.S.-Style Multi-Claimant Actions Take Another Step in the U.K.: Le Patourel v BT, the First U.K. Opt-Out Judgment Goes to the Defense

REGULATORY REVIEW

PFAS in the Spotlight: EPA and FDA Zero in on Seafood and Water

The 2024 PFAS Strategic Roadmap highlights EPA’s desire to implement further regulation and oversight to study and reduce exposure to PFAS. Seafood and water-processing may be EPA’s new focus after FDA findings. Read more »

HOT TOPICS

Online Retailer Avoids Liability in Suicide Cases (For Now)

Washington state and federal courts dismissed claims alleging Amazon is liable for selling a product used to commit suicide; but debate continues as to whether traditional rules need to adapt to address online selling and marketing. Read more »

EXPERTS EXAMINED

AI Expert Challenged for Relying on AI “Hallucinations”

An AI expert’s testimony that relied on “hallucination” citations to support substantive claims is being challenged under Daubert and Rule 702. Read more »

JURSDICTIONAL JABBER

Ohio Supreme Court Rules Public Nuisance Claims Against Retail Pharmacies Barred by State Law

A new decision from the Ohio Supreme Court finds that opioid-related public nuisance claims against retail pharmacies chains are barred by state law. Read more »

INTERNATIONAL INTRIGUE

U.S.-Style Multi-Claimant Actions Take Another Step in the U.K.: Le Patourel v BT, the First U.K. Opt-Out Judgment Goes to the Defense

In December 2024, the U.K. Competition Appeal Tribunal handed down its defense ruling in Le Patourel v BT—the first opt-out, collective action trial in the United Kingdom. Read more »